NorthWest Biotherapeutics Inc (NWBO)

[barnstormer]

DD, concur that the most likely cause for delay is related to Flaskworks inclusion into the MAA after the initial filing. We do disagree in that I believe it constituted a material event that should have been reported to shareholders. Doubtful it would be a manual production issue at this point or (a) the MAA would not have been accepted and (b) manual process has been accepted in the MHRA Specials program. Good questions for the Q&A section of the ASM. You should file them if you haven't already.